Drug General Information
Drug ID
D07PRC
Former ID
DIB007050
Drug Name
BAL-30072
Drug Type
Small molecular drug
Indication Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] Phase 1 [549110]
Company
Basilea Pharmaceutica International Ltd
Structure
Download
2D MOL

3D MOL

Formula
C16H18N6O10S2
Canonical SMILES
OS(=O)(=O)ON1C(C)(C)[C@@H](C1=O)NC(=O)/C(=N\OCc1cc(=O)c<br />(cn1O)O)/c1csc(n1)N
PubChem Compound ID
Target and Pathway
Target(s) Bacterial penicillin binding protein Target Info Inhibitor [530802]
References
Ref 549110Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032341)
Ref 530802In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob Agents Chemother. 2010 Jun;54(6):2291-302.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.